nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—ALB—Levothyroxine—hypothyroidism	0.175	0.336	CbGbCtD
Sulindac—ALB—Liothyronine—hypothyroidism	0.175	0.336	CbGbCtD
Sulindac—ALB—Liotrix—hypothyroidism	0.171	0.328	CbGbCtD
Sulindac—PPARD—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0103	0.0763	CbGpPWpGaD
Sulindac—PTGDR2—heart—hypothyroidism	0.00947	0.0624	CbGeAlD
Sulindac—PPARD—Nuclear Receptors—THRA—hypothyroidism	0.00757	0.0563	CbGpPWpGaD
Sulindac—PTGDR2—blood—hypothyroidism	0.00707	0.0465	CbGeAlD
Sulindac—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00678	0.0354	CcSEcCtD
Sulindac—PPARD—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00661	0.0492	CbGpPWpGaD
Sulindac—PPARD—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00598	0.0445	CbGpPWpGaD
Sulindac—PTGDR2—cerebellum—hypothyroidism	0.0054	0.0356	CbGeAlD
Sulindac—AKR1B1—adrenal cortex—hypothyroidism	0.0052	0.0343	CbGeAlD
Sulindac—AKR1B1—heart—hypothyroidism	0.00503	0.0331	CbGeAlD
Sulindac—PPARD—Nuclear Receptors—THRB—hypothyroidism	0.00488	0.0363	CbGpPWpGaD
Sulindac—AKR1B1—cardiovascular system—hypothyroidism	0.00475	0.0313	CbGeAlD
Sulindac—CYP1A2—urine—hypothyroidism	0.00447	0.0294	CbGeAlD
Sulindac—AKR1B1—gonad—hypothyroidism	0.00431	0.0284	CbGeAlD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.00428	0.0318	CbGpPWpGaD
Sulindac—AKR1B1—pituitary gland—hypothyroidism	0.0042	0.0277	CbGeAlD
Sulindac—AKR1B1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00399	0.0297	CbGpPWpGaD
Sulindac—PPARD—heart—hypothyroidism	0.00396	0.0261	CbGeAlD
Sulindac—MAPK3—Nongenotropic Androgen signaling—SHBG—hypothyroidism	0.00387	0.0288	CbGpPWpGaD
Sulindac—PPARD—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00386	0.0287	CbGpPWpGaD
Sulindac—Coma—Dextrothyroxine—hypothyroidism	0.0038	0.0198	CcSEcCtD
Sulindac—Coma—Levothyroxine—hypothyroidism	0.0038	0.0198	CcSEcCtD
Sulindac—Arrhythmia—Liothyronine—hypothyroidism	0.0038	0.0198	CcSEcCtD
Sulindac—MAPK3—adrenal cortex—hypothyroidism	0.00377	0.0248	CbGeAlD
Sulindac—AKR1B1—adrenal gland—hypothyroidism	0.00376	0.0247	CbGeAlD
Sulindac—AKR1B1—blood—hypothyroidism	0.00376	0.0247	CbGeAlD
Sulindac—MAPK3—heart—hypothyroidism	0.00365	0.024	CbGeAlD
Sulindac—AKR1B1—thyroid gland—hypothyroidism	0.00362	0.0239	CbGeAlD
Sulindac—Tenderness—Liotrix—hypothyroidism	0.00351	0.0183	CcSEcCtD
Sulindac—AKR1B1—female gonad—hypothyroidism	0.0035	0.0231	CbGeAlD
Sulindac—MAPK3—cardiovascular system—hypothyroidism	0.00344	0.0227	CbGeAlD
Sulindac—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00333	0.0174	CcSEcCtD
Sulindac—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00333	0.0174	CcSEcCtD
Sulindac—Hypertension—Liothyronine—hypothyroidism	0.0032	0.0167	CcSEcCtD
Sulindac—MAPK3—gonad—hypothyroidism	0.00312	0.0206	CbGeAlD
Sulindac—AKR1B1—testis—hypothyroidism	0.00311	0.0205	CbGeAlD
Sulindac—MAPK3—pituitary gland—hypothyroidism	0.00305	0.0201	CbGeAlD
Sulindac—PPARD—adrenal gland—hypothyroidism	0.00295	0.0195	CbGeAlD
Sulindac—Tachycardia—Liothyronine—hypothyroidism	0.00295	0.0154	CcSEcCtD
Sulindac—AKR1B1—liver—hypothyroidism	0.00294	0.0193	CbGeAlD
Sulindac—AKR1B1—cerebellum—hypothyroidism	0.00287	0.0189	CbGeAlD
Sulindac—PPARD—thyroid gland—hypothyroidism	0.00285	0.0188	CbGeAlD
Sulindac—Hypotension—Liothyronine—hypothyroidism	0.00283	0.0147	CcSEcCtD
Sulindac—Coma—Liotrix—hypothyroidism	0.0028	0.0146	CcSEcCtD
Sulindac—PPARD—female gonad—hypothyroidism	0.00275	0.0181	CbGeAlD
Sulindac—MAPK3—adrenal gland—hypothyroidism	0.00272	0.0179	CbGeAlD
Sulindac—MAPK3—blood—hypothyroidism	0.00272	0.0179	CbGeAlD
Sulindac—Muscular weakness—Levothyroxine—hypothyroidism	0.00266	0.0139	CcSEcCtD
Sulindac—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00266	0.0139	CcSEcCtD
Sulindac—MAPK3—thyroid gland—hypothyroidism	0.00263	0.0173	CbGeAlD
Sulindac—PPARD—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.00257	0.0191	CbGpPWpGaD
Sulindac—Sweating increased—Dextrothyroxine—hypothyroidism	0.00254	0.0133	CcSEcCtD
Sulindac—Sweating increased—Levothyroxine—hypothyroidism	0.00254	0.0133	CcSEcCtD
Sulindac—MAPK3—female gonad—hypothyroidism	0.00254	0.0167	CbGeAlD
Sulindac—MAPK3—TSH signaling pathway—PAX8—hypothyroidism	0.00249	0.0185	CbGpPWpGaD
Sulindac—Cardiac failure congestive—Liotrix—hypothyroidism	0.00245	0.0128	CcSEcCtD
Sulindac—PPARD—testis—hypothyroidism	0.00244	0.0161	CbGeAlD
Sulindac—Body temperature increased—Liothyronine—hypothyroidism	0.00239	0.0125	CcSEcCtD
Sulindac—Renal impairment—Liotrix—hypothyroidism	0.00234	0.0122	CcSEcCtD
Sulindac—PPARD—liver—hypothyroidism	0.00231	0.0152	CbGeAlD
Sulindac—PPARD—cerebellum—hypothyroidism	0.00226	0.0149	CbGeAlD
Sulindac—MAPK3—testis—hypothyroidism	0.00225	0.0148	CbGeAlD
Sulindac—Sweating—Levothyroxine—hypothyroidism	0.00223	0.0116	CcSEcCtD
Sulindac—Sweating—Dextrothyroxine—hypothyroidism	0.00223	0.0116	CcSEcCtD
Sulindac—MAPK3—liver—hypothyroidism	0.00213	0.014	CbGeAlD
Sulindac—PPARD—NRF2 pathway—SLC5A7—hypothyroidism	0.0021	0.0156	CbGpPWpGaD
Sulindac—MAPK3—cerebellum—hypothyroidism	0.00208	0.0137	CbGeAlD
Sulindac—Muscular weakness—Liotrix—hypothyroidism	0.00196	0.0102	CcSEcCtD
Sulindac—Flushing—Dextrothyroxine—hypothyroidism	0.00194	0.0101	CcSEcCtD
Sulindac—Flushing—Levothyroxine—hypothyroidism	0.00194	0.0101	CcSEcCtD
Sulindac—Bronchospasm—Liotrix—hypothyroidism	0.00189	0.00985	CcSEcCtD
Sulindac—Sweating increased—Liotrix—hypothyroidism	0.00187	0.00976	CcSEcCtD
Sulindac—Arrhythmia—Levothyroxine—hypothyroidism	0.00187	0.00974	CcSEcCtD
Sulindac—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00187	0.00974	CcSEcCtD
Sulindac—Alopecia—Dextrothyroxine—hypothyroidism	0.00185	0.00963	CcSEcCtD
Sulindac—Alopecia—Levothyroxine—hypothyroidism	0.00185	0.00963	CcSEcCtD
Sulindac—Tension—Dextrothyroxine—hypothyroidism	0.00179	0.00931	CcSEcCtD
Sulindac—Tension—Levothyroxine—hypothyroidism	0.00179	0.00931	CcSEcCtD
Sulindac—Nervousness—Dextrothyroxine—hypothyroidism	0.00177	0.00921	CcSEcCtD
Sulindac—Nervousness—Levothyroxine—hypothyroidism	0.00177	0.00921	CcSEcCtD
Sulindac—ALB—heart—hypothyroidism	0.00174	0.0115	CbGeAlD
Sulindac—Renal failure—Liotrix—hypothyroidism	0.00168	0.00878	CcSEcCtD
Sulindac—Angioedema—Levothyroxine—hypothyroidism	0.00166	0.00867	CcSEcCtD
Sulindac—Angioedema—Dextrothyroxine—hypothyroidism	0.00166	0.00867	CcSEcCtD
Sulindac—Sweating—Liotrix—hypothyroidism	0.00164	0.00856	CcSEcCtD
Sulindac—Palpitations—Dextrothyroxine—hypothyroidism	0.00161	0.00838	CcSEcCtD
Sulindac—Palpitations—Levothyroxine—hypothyroidism	0.00161	0.00838	CcSEcCtD
Sulindac—MAPK3—Growth hormone receptor signaling—PRL—hypothyroidism	0.00161	0.012	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—ZNF764—hypothyroidism	0.0016	0.0119	CbGpPWpGaD
Sulindac—Convulsion—Dextrothyroxine—hypothyroidism	0.00158	0.00822	CcSEcCtD
Sulindac—Convulsion—Levothyroxine—hypothyroidism	0.00158	0.00822	CcSEcCtD
Sulindac—Arthralgia—Levothyroxine—hypothyroidism	0.00155	0.00808	CcSEcCtD
Sulindac—Arthralgia—Dextrothyroxine—hypothyroidism	0.00155	0.00808	CcSEcCtD
Sulindac—Shock—Levothyroxine—hypothyroidism	0.00146	0.00762	CcSEcCtD
Sulindac—Shock—Dextrothyroxine—hypothyroidism	0.00146	0.00762	CcSEcCtD
Sulindac—Tachycardia—Dextrothyroxine—hypothyroidism	0.00145	0.00756	CcSEcCtD
Sulindac—Tachycardia—Levothyroxine—hypothyroidism	0.00145	0.00756	CcSEcCtD
Sulindac—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00144	0.00748	CcSEcCtD
Sulindac—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00144	0.00748	CcSEcCtD
Sulindac—Flushing—Liotrix—hypothyroidism	0.00143	0.00744	CcSEcCtD
Sulindac—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00138	0.0103	CbGpPWpGaD
Sulindac—Arrhythmia—Liotrix—hypothyroidism	0.00137	0.00716	CcSEcCtD
Sulindac—Alopecia—Liotrix—hypothyroidism	0.00136	0.00708	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00135	0.00705	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00135	0.00705	CcSEcCtD
Sulindac—Insomnia—Levothyroxine—hypothyroidism	0.00134	0.007	CcSEcCtD
Sulindac—Insomnia—Dextrothyroxine—hypothyroidism	0.00134	0.007	CcSEcCtD
Sulindac—MAPK3—Interleukin-11 Signaling Pathway—BGLAP—hypothyroidism	0.00134	0.00998	CbGpPWpGaD
Sulindac—Dyspnoea—Levothyroxine—hypothyroidism	0.00132	0.0069	CcSEcCtD
Sulindac—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00132	0.0069	CcSEcCtD
Sulindac—Flatulence—Liotrix—hypothyroidism	0.00132	0.00688	CcSEcCtD
Sulindac—Tension—Liotrix—hypothyroidism	0.00131	0.00685	CcSEcCtD
Sulindac—Dysgeusia—Liotrix—hypothyroidism	0.00131	0.00683	CcSEcCtD
Sulindac—Nervousness—Liotrix—hypothyroidism	0.0013	0.00678	CcSEcCtD
Sulindac—ALB—adrenal gland—hypothyroidism	0.0013	0.00855	CbGeAlD
Sulindac—ALB—Transport of organic anions—AVP—hypothyroidism	0.00129	0.00957	CbGpPWpGaD
Sulindac—Fatigue—Dextrothyroxine—hypothyroidism	0.00128	0.00668	CcSEcCtD
Sulindac—Fatigue—Levothyroxine—hypothyroidism	0.00128	0.00668	CcSEcCtD
Sulindac—Vision blurred—Liotrix—hypothyroidism	0.00126	0.00658	CcSEcCtD
Sulindac—AKR1B1—Metabolism—IYD—hypothyroidism	0.00126	0.00934	CbGpPWpGaD
Sulindac—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00122	0.00638	CcSEcCtD
Sulindac—Feeling abnormal—Levothyroxine—hypothyroidism	0.00122	0.00638	CcSEcCtD
Sulindac—Angioedema—Liotrix—hypothyroidism	0.00122	0.00638	CcSEcCtD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00122	0.00906	CbGpPWpGaD
Sulindac—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00121	0.00633	CcSEcCtD
Sulindac—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00121	0.00633	CcSEcCtD
Sulindac—MAPK3—Osteopontin-mediated events—VAV3—hypothyroidism	0.00121	0.00901	CbGpPWpGaD
Sulindac—Syncope—Liotrix—hypothyroidism	0.0012	0.00626	CcSEcCtD
Sulindac—MAPK3—ErbB4 signaling events—PRL—hypothyroidism	0.00119	0.00884	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Stem cell factor receptor (c-Kit)—SH2B3—hypothyroidism	0.00119	0.00881	CbGpPWpGaD
Sulindac—Palpitations—Liotrix—hypothyroidism	0.00118	0.00617	CcSEcCtD
Sulindac—Urticaria—Dextrothyroxine—hypothyroidism	0.00118	0.00615	CcSEcCtD
Sulindac—Urticaria—Levothyroxine—hypothyroidism	0.00118	0.00615	CcSEcCtD
Sulindac—Loss of consciousness—Liotrix—hypothyroidism	0.00118	0.00613	CcSEcCtD
Sulindac—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00117	0.00612	CcSEcCtD
Sulindac—Body temperature increased—Levothyroxine—hypothyroidism	0.00117	0.00612	CcSEcCtD
Sulindac—Convulsion—Liotrix—hypothyroidism	0.00116	0.00605	CcSEcCtD
Sulindac—Hypertension—Liotrix—hypothyroidism	0.00116	0.00602	CcSEcCtD
Sulindac—Arthralgia—Liotrix—hypothyroidism	0.00114	0.00594	CcSEcCtD
Sulindac—Chest pain—Liotrix—hypothyroidism	0.00114	0.00594	CcSEcCtD
Sulindac—MAPK3—FGF signaling pathway—BGLAP—hypothyroidism	0.00114	0.00847	CbGpPWpGaD
Sulindac—CYP1A1—heart—hypothyroidism	0.00113	0.00743	CbGeAlD
Sulindac—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00112	0.00831	CbGpPWpGaD
Sulindac—Oedema—Liotrix—hypothyroidism	0.00109	0.0057	CcSEcCtD
Sulindac—Anaphylactic shock—Liotrix—hypothyroidism	0.00109	0.0057	CcSEcCtD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00109	0.00807	CbGpPWpGaD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00109	0.00807	CbGpPWpGaD
Sulindac—MAPK3—TSH signaling pathway—TSHB—hypothyroidism	0.00108	0.00805	CbGpPWpGaD
Sulindac—MAPK3—TSH signaling pathway—TSHR—hypothyroidism	0.00108	0.00805	CbGpPWpGaD
Sulindac—Shock—Liotrix—hypothyroidism	0.00107	0.0056	CcSEcCtD
Sulindac—ALB—testis—hypothyroidism	0.00107	0.00707	CbGeAlD
Sulindac—AKR1B1—Metabolism—ATP5O—hypothyroidism	0.00107	0.00794	CbGpPWpGaD
Sulindac—Tachycardia—Liotrix—hypothyroidism	0.00107	0.00556	CcSEcCtD
Sulindac—Asthenia—Dextrothyroxine—hypothyroidism	0.00107	0.00555	CcSEcCtD
Sulindac—Asthenia—Levothyroxine—hypothyroidism	0.00107	0.00555	CcSEcCtD
Sulindac—Hyperhidrosis—Liotrix—hypothyroidism	0.00106	0.00551	CcSEcCtD
Sulindac—Pruritus—Dextrothyroxine—hypothyroidism	0.00105	0.00548	CcSEcCtD
Sulindac—Pruritus—Levothyroxine—hypothyroidism	0.00105	0.00548	CcSEcCtD
Sulindac—Anorexia—Liotrix—hypothyroidism	0.00104	0.00543	CcSEcCtD
Sulindac—PPARD—Generic Transcription Pathway—THRA—hypothyroidism	0.00103	0.00769	CbGpPWpGaD
Sulindac—Hypotension—Liotrix—hypothyroidism	0.00102	0.00532	CcSEcCtD
Sulindac—Diarrhoea—Levothyroxine—hypothyroidism	0.00102	0.0053	CcSEcCtD
Sulindac—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00102	0.0053	CcSEcCtD
Sulindac—ALB—liver—hypothyroidism	0.00102	0.00669	CbGeAlD
Sulindac—PTGS1—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00101	0.00749	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—TPO—hypothyroidism	0.001	0.00747	CbGpPWpGaD
Sulindac—MAPK3—Integrins in angiogenesis—PIK3C2A—hypothyroidism	0.001	0.00744	CbGpPWpGaD
Sulindac—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000995	0.00519	CcSEcCtD
Sulindac—PTGS1—heart—hypothyroidism	0.000991	0.00653	CbGeAlD
Sulindac—Insomnia—Liotrix—hypothyroidism	0.000988	0.00515	CcSEcCtD
Sulindac—Paraesthesia—Liotrix—hypothyroidism	0.000981	0.00511	CcSEcCtD
Sulindac—PTGS2—adrenal cortex—hypothyroidism	0.00098	0.00645	CbGeAlD
Sulindac—Dyspnoea—Liotrix—hypothyroidism	0.000974	0.00508	CcSEcCtD
Sulindac—Decreased appetite—Liotrix—hypothyroidism	0.00095	0.00495	CcSEcCtD
Sulindac—PTGS2—heart—hypothyroidism	0.000948	0.00624	CbGeAlD
Sulindac—Vomiting—Levothyroxine—hypothyroidism	0.000944	0.00492	CcSEcCtD
Sulindac—Vomiting—Dextrothyroxine—hypothyroidism	0.000944	0.00492	CcSEcCtD
Sulindac—Fatigue—Liotrix—hypothyroidism	0.000942	0.00491	CcSEcCtD
Sulindac—Rash—Levothyroxine—hypothyroidism	0.000936	0.00488	CcSEcCtD
Sulindac—Rash—Dextrothyroxine—hypothyroidism	0.000936	0.00488	CcSEcCtD
Sulindac—PTGS1—cardiovascular system—hypothyroidism	0.000935	0.00616	CbGeAlD
Sulindac—Dermatitis—Levothyroxine—hypothyroidism	0.000935	0.00488	CcSEcCtD
Sulindac—Dermatitis—Dextrothyroxine—hypothyroidism	0.000935	0.00488	CcSEcCtD
Sulindac—Constipation—Liotrix—hypothyroidism	0.000934	0.00487	CcSEcCtD
Sulindac—MAPK3—FCERI mediated MAPK activation—VAV3—hypothyroidism	0.000932	0.00693	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00093	0.00692	CbGpPWpGaD
Sulindac—Headache—Levothyroxine—hypothyroidism	0.00093	0.00485	CcSEcCtD
Sulindac—Headache—Dextrothyroxine—hypothyroidism	0.00093	0.00485	CcSEcCtD
Sulindac—PTGDR2—GPCR ligand binding—TRH—hypothyroidism	0.000927	0.0069	CbGpPWpGaD
Sulindac—Feeling abnormal—Liotrix—hypothyroidism	0.0009	0.00469	CcSEcCtD
Sulindac—PTGS2—cardiovascular system—hypothyroidism	0.000894	0.00589	CbGeAlD
Sulindac—Gastrointestinal pain—Liotrix—hypothyroidism	0.000893	0.00466	CcSEcCtD
Sulindac—MAPK3—SHC-related events triggered by IGF1R—IGF1—hypothyroidism	0.000886	0.00659	CbGpPWpGaD
Sulindac—Nausea—Levothyroxine—hypothyroidism	0.000882	0.0046	CcSEcCtD
Sulindac—Nausea—Dextrothyroxine—hypothyroidism	0.000882	0.0046	CcSEcCtD
Sulindac—Urticaria—Liotrix—hypothyroidism	0.000868	0.00452	CcSEcCtD
Sulindac—Body temperature increased—Liotrix—hypothyroidism	0.000863	0.0045	CcSEcCtD
Sulindac—CYP1A2—blood—hypothyroidism	0.000854	0.00562	CbGeAlD
Sulindac—CYP1A1—blood—hypothyroidism	0.000842	0.00555	CbGeAlD
Sulindac—PPARD—NRF2 pathway—SLC5A5—hypothyroidism	0.00084	0.00625	CbGpPWpGaD
Sulindac—PTGS1—pituitary gland—hypothyroidism	0.000828	0.00546	CbGeAlD
Sulindac—PTGDR2—GPCR ligand binding—TSHB—hypothyroidism	0.000826	0.00615	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—TSHR—hypothyroidism	0.000826	0.00615	CbGpPWpGaD
Sulindac—CYP1A2—thyroid gland—hypothyroidism	0.000824	0.00543	CbGeAlD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.000816	0.00607	CbGpPWpGaD
Sulindac—CYP1A1—thyroid gland—hypothyroidism	0.000813	0.00535	CbGeAlD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—PIK3C2A—hypothyroidism	0.00081	0.00603	CbGpPWpGaD
Sulindac—Hypersensitivity—Liotrix—hypothyroidism	0.000805	0.0042	CcSEcCtD
Sulindac—PTGS2—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.000799	0.00595	CbGpPWpGaD
Sulindac—PTGS2—pituitary gland—hypothyroidism	0.000792	0.00521	CbGeAlD
Sulindac—CYP1A1—female gonad—hypothyroidism	0.000785	0.00517	CbGeAlD
Sulindac—Asthenia—Liotrix—hypothyroidism	0.000784	0.00409	CcSEcCtD
Sulindac—Pruritus—Liotrix—hypothyroidism	0.000773	0.00403	CcSEcCtD
Sulindac—PPARD—Gene Expression—ZNF764—hypothyroidism	0.000772	0.00574	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—SH2B3—hypothyroidism	0.000752	0.0056	CbGpPWpGaD
Sulindac—Diarrhoea—Liotrix—hypothyroidism	0.000747	0.0039	CcSEcCtD
Sulindac—MAPK3—Regulation of actin dynamics for phagocytic cup formation—VAV3—hypothyroidism	0.000744	0.00553	CbGpPWpGaD
Sulindac—PTGS1—adrenal gland—hypothyroidism	0.00074	0.00487	CbGeAlD
Sulindac—PTGS1—blood—hypothyroidism	0.00074	0.00487	CbGeAlD
Sulindac—PPARD—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000736	0.00548	CbGpPWpGaD
Sulindac—Dizziness—Liotrix—hypothyroidism	0.000722	0.00377	CcSEcCtD
Sulindac—PTGS1—thyroid gland—hypothyroidism	0.000714	0.0047	CbGeAlD
Sulindac—PTGS2—adrenal gland—hypothyroidism	0.000707	0.00466	CbGeAlD
Sulindac—PTGS2—blood—hypothyroidism	0.000707	0.00466	CbGeAlD
Sulindac—Vomiting—Liotrix—hypothyroidism	0.000695	0.00362	CcSEcCtD
Sulindac—PTGS1—female gonad—hypothyroidism	0.00069	0.00454	CbGeAlD
Sulindac—Rash—Liotrix—hypothyroidism	0.000689	0.00359	CcSEcCtD
Sulindac—Dermatitis—Liotrix—hypothyroidism	0.000688	0.00359	CcSEcCtD
Sulindac—MAPK3—Integrins in angiogenesis—VAV3—hypothyroidism	0.000687	0.00511	CbGpPWpGaD
Sulindac—Headache—Liotrix—hypothyroidism	0.000684	0.00357	CcSEcCtD
Sulindac—CYP1A2—liver—hypothyroidism	0.000668	0.0044	CbGeAlD
Sulindac—PPARD—Generic Transcription Pathway—THRB—hypothyroidism	0.000666	0.00495	CbGpPWpGaD
Sulindac—PTGS2—female gonad—hypothyroidism	0.000659	0.00434	CbGeAlD
Sulindac—CYP1A1—liver—hypothyroidism	0.000659	0.00434	CbGeAlD
Sulindac—Nausea—Liotrix—hypothyroidism	0.000649	0.00338	CcSEcCtD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00064	0.00476	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000626	0.00466	CbGpPWpGaD
Sulindac—PTGS1—testis—hypothyroidism	0.000612	0.00403	CbGeAlD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.000601	0.00447	CbGpPWpGaD
Sulindac—MAPK3—Fcgamma receptor (FCGR) dependent phagocytosis—VAV3—hypothyroidism	0.000562	0.00418	CbGpPWpGaD
Sulindac—PTGS2—liver—hypothyroidism	0.000553	0.00364	CbGeAlD
Sulindac—PTGS2—cerebellum—hypothyroidism	0.00054	0.00356	CbGeAlD
Sulindac—PTGDR2—G alpha (i) signalling events—POMC—hypothyroidism	0.000535	0.00398	CbGpPWpGaD
Sulindac—MAPK3—Ceramide signaling pathway—IGF1—hypothyroidism	0.000526	0.00391	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000525	0.00391	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—TRH—hypothyroidism	0.000524	0.0039	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000519	0.00386	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—VAV3—hypothyroidism	0.000516	0.00384	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000503	0.00374	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—THRA—hypothyroidism	0.000498	0.0037	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—AVP—hypothyroidism	0.000487	0.00362	CbGpPWpGaD
Sulindac—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000477	0.00355	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—TRH—hypothyroidism	0.000476	0.00354	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—PIK3C2A—hypothyroidism	0.000475	0.00353	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000472	0.00351	CbGpPWpGaD
Sulindac—MAPK3—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.000472	0.00351	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—TSHB—hypothyroidism	0.000467	0.00347	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—TSHR—hypothyroidism	0.000467	0.00347	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—TSHB—hypothyroidism	0.000465	0.00346	CbGpPWpGaD
Sulindac—PPARD—Adipogenesis—IGF1—hypothyroidism	0.000464	0.00345	CbGpPWpGaD
Sulindac—PPARD—Metabolism—IYD—hypothyroidism	0.000455	0.00338	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.00045	0.00334	CbGpPWpGaD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000425	0.00316	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—VAV3—hypothyroidism	0.000424	0.00316	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—TSHB—hypothyroidism	0.000424	0.00315	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—TSHR—hypothyroidism	0.000424	0.00315	CbGpPWpGaD
Sulindac—MAPK3—Integrins in angiogenesis—IGF1—hypothyroidism	0.000423	0.00315	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—PIK3C2A—hypothyroidism	0.000414	0.00308	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000409	0.00304	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—ZNF764—hypothyroidism	0.000394	0.00293	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—CLTC—hypothyroidism	0.000393	0.00292	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ATP5O—hypothyroidism	0.000387	0.00288	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—PRL—hypothyroidism	0.000367	0.00273	CbGpPWpGaD
Sulindac—PPARD—Metabolism—TPO—hypothyroidism	0.000364	0.00271	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.000356	0.00265	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—VAV3—hypothyroidism	0.000355	0.00264	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—NKX2-5—hypothyroidism	0.000355	0.00264	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—SLC5A5—hypothyroidism	0.000348	0.00259	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000337	0.00251	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.000336	0.0025	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000326	0.00242	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CLTC—hypothyroidism	0.000325	0.00242	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—POMC—hypothyroidism	0.000325	0.00242	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—POMC—hypothyroidism	0.000324	0.00241	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—IGF1—hypothyroidism	0.000321	0.00239	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—THRB—hypothyroidism	0.000321	0.00238	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—VAV3—hypothyroidism	0.000319	0.00238	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000318	0.00237	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—IGF1—hypothyroidism	0.000312	0.00232	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—VAV3—hypothyroidism	0.000301	0.00224	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.000301	0.00224	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—VAV3—hypothyroidism	0.000286	0.00212	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TRH—hypothyroidism	0.000281	0.00209	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—CLTC—hypothyroidism	0.000281	0.00209	CbGpPWpGaD
Sulindac—PTGS1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000278	0.00207	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—AVP—hypothyroidism	0.000275	0.00205	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00027	0.00201	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000264	0.00196	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—VAV3—hypothyroidism	0.000259	0.00193	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—THRA—hypothyroidism	0.000254	0.00189	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000252	0.00187	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TSHR—hypothyroidism	0.000251	0.00186	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TSHB—hypothyroidism	0.000251	0.00186	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00025	0.00186	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—AVP—hypothyroidism	0.00025	0.00186	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000248	0.00184	CbGpPWpGaD
Sulindac—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000241	0.0018	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.000225	0.00167	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—SH2B3—hypothyroidism	0.000223	0.00166	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—VAV3—hypothyroidism	0.000205	0.00152	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000197	0.00147	CbGpPWpGaD
Sulindac—CYP1A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000196	0.00146	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—SH2B3—hypothyroidism	0.000189	0.00141	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—VAV3—hypothyroidism	0.000185	0.00138	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—POMC—hypothyroidism	0.000183	0.00136	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—POMC—hypothyroidism	0.000182	0.00135	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NKX2-5—hypothyroidism	0.000181	0.00135	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000174	0.0013	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—IYD—hypothyroidism	0.000174	0.00129	CbGpPWpGaD
Sulindac—PPARD—Metabolism—TSHB—hypothyroidism	0.000168	0.00125	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—IGF1—hypothyroidism	0.000168	0.00125	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—POMC—hypothyroidism	0.000166	0.00124	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—PRL—hypothyroidism	0.000166	0.00123	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000165	0.00123	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—THRB—hypothyroidism	0.000164	0.00122	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.00016	0.00119	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000155	0.00115	CbGpPWpGaD
Sulindac—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000154	0.00114	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—VAV3—hypothyroidism	0.000153	0.00114	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PIK3C2A—hypothyroidism	0.00015	0.00112	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000148	0.0011	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ATP5O—hypothyroidism	0.000148	0.0011	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AVP—hypothyroidism	0.000148	0.0011	CbGpPWpGaD
Sulindac—PTGS1—Biological oxidations—POMC—hypothyroidism	0.000148	0.0011	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CLTC—hypothyroidism	0.000144	0.00107	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—TPO—hypothyroidism	0.000139	0.00103	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—IYD—hypothyroidism	0.000138	0.00103	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000137	0.00102	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TRH—hypothyroidism	0.000137	0.00102	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—VAV3—hypothyroidism	0.000132	0.000984	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00013	0.000968	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—VAV3—hypothyroidism	0.00013	0.000965	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000129	0.000959	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000127	0.000946	CbGpPWpGaD
Sulindac—PPARD—Metabolism—SLC5A5—hypothyroidism	0.000126	0.000938	CbGpPWpGaD
Sulindac—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000125	0.000928	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—IYD—hypothyroidism	0.000123	0.000912	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TSHB—hypothyroidism	0.000122	0.000905	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TSHR—hypothyroidism	0.000122	0.000905	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000121	0.000901	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ATP5O—hypothyroidism	0.000117	0.000874	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—VAV3—hypothyroidism	0.000117	0.000869	CbGpPWpGaD
Sulindac—ALB—Metabolism—IYD—hypothyroidism	0.000112	0.000831	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—TPO—hypothyroidism	0.00011	0.000821	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ATP5O—hypothyroidism	0.000104	0.000775	CbGpPWpGaD
Sulindac—CYP1A1—Biological oxidations—POMC—hypothyroidism	0.000104	0.000773	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000104	0.00077	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000102	0.000762	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000102	0.000761	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—AVP—hypothyroidism	0.0001	0.000745	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—POMC—hypothyroidism	9.81e-05	0.00073	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TPO—hypothyroidism	9.8e-05	0.000729	CbGpPWpGaD
Sulindac—ALB—Metabolism—ATP5O—hypothyroidism	9.5e-05	0.000707	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IGF1—hypothyroidism	9.44e-05	0.000702	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CLTC—hypothyroidism	9.33e-05	0.000694	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SH2B3—hypothyroidism	9.09e-05	0.000676	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.08e-05	0.000676	CbGpPWpGaD
Sulindac—ALB—Metabolism—TPO—hypothyroidism	8.94e-05	0.000665	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.28e-05	0.000616	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TRH—hypothyroidism	8.07e-05	0.0006	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IGF1—hypothyroidism	7.99e-05	0.000594	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—IYD—hypothyroidism	7.82e-05	0.000581	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	7.46e-05	0.000555	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—VAV3—hypothyroidism	7.44e-05	0.000554	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PRL—hypothyroidism	7.35e-05	0.000547	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TSHB—hypothyroidism	7.19e-05	0.000535	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TSHR—hypothyroidism	7.19e-05	0.000535	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AVP—hypothyroidism	7.17e-05	0.000533	CbGpPWpGaD
Sulindac—MAPK3—Immune System—VAV3—hypothyroidism	6.8e-05	0.000506	CbGpPWpGaD
Sulindac—MAPK3—Disease—PRL—hypothyroidism	6.79e-05	0.000505	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ATP5O—hypothyroidism	6.65e-05	0.000494	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—POMC—hypothyroidism	6.63e-05	0.000493	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.61e-05	0.000492	CbGpPWpGaD
Sulindac—PPARD—Metabolism—POMC—hypothyroidism	6.6e-05	0.000491	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—TSHB—hypothyroidism	6.44e-05	0.000479	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SH2B3—hypothyroidism	6.41e-05	0.000477	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TPO—hypothyroidism	6.25e-05	0.000465	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VAV3—hypothyroidism	6.24e-05	0.000464	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.79e-05	0.000431	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3C2A—hypothyroidism	5.74e-05	0.000427	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.66e-05	0.000421	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	5.21e-05	0.000387	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—TSHB—hypothyroidism	5.11e-05	0.00038	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SLC5A5—hypothyroidism	4.82e-05	0.000359	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—POMC—hypothyroidism	4.77e-05	0.000355	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PRL—hypothyroidism	4.75e-05	0.000354	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3C2A—hypothyroidism	4.56e-05	0.000339	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TSHB—hypothyroidism	4.54e-05	0.000338	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.5e-05	0.000334	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VAV3—hypothyroidism	4.4e-05	0.000327	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AVP—hypothyroidism	4.24e-05	0.000315	CbGpPWpGaD
Sulindac—ALB—Metabolism—TSHB—hypothyroidism	4.14e-05	0.000308	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3C2A—hypothyroidism	4.04e-05	0.000301	CbGpPWpGaD
Sulindac—PTGS2—Disease—PRL—hypothyroidism	4.04e-05	0.0003	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.99e-05	0.000297	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IGF1—hypothyroidism	3.84e-05	0.000286	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SLC5A5—hypothyroidism	3.83e-05	0.000285	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3C2A—hypothyroidism	3.69e-05	0.000274	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.64e-05	0.000271	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC5A5—hypothyroidism	3.4e-05	0.000253	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC5A5—hypothyroidism	3.1e-05	0.00023	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TSHB—hypothyroidism	2.89e-05	0.000215	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—POMC—hypothyroidism	2.82e-05	0.000209	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF1—hypothyroidism	2.71e-05	0.000201	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	2.58e-05	0.000192	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.54e-05	0.000189	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—POMC—hypothyroidism	2.52e-05	0.000188	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC5A5—hypothyroidism	2.17e-05	0.000161	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—POMC—hypothyroidism	2e-05	0.000149	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—POMC—hypothyroidism	1.78e-05	0.000132	CbGpPWpGaD
Sulindac—ALB—Metabolism—POMC—hypothyroidism	1.62e-05	0.000121	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—POMC—hypothyroidism	1.13e-05	8.43e-05	CbGpPWpGaD
